Concourse Financial Group Securities, Inc. Iso Plexis Corp Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	N/A
Q2 2024 Jul 23, 2024	BUY	N/A
Q1 2024 Apr 30, 2024	BUY	N/A
Q4 2023 Feb 07, 2024	BUY	N/A
Q3 2023 Oct 30, 2023	BUY	N/A
Q3 2023 Oct 25, 2023	BUY	N/A
Q2 2023 Aug 10, 2023	BUY	N/A
Q1 2023 May 15, 2023	BUY	$0.0 - $1.6 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$0.66 - $1.8 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.75 - $3.74 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.79 - $3.34 $0 - $0
Q1 2022 May 09, 2022	BUY	$3.43 - $10.07 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$4.9 - $15.7 $0 - $0

Others Institutions Holding ISO

# of Institutions

Shares Held

11.8K

Call Options Held

Put Options Held

Corient Capital Partners, LLC Newport Beach, CA

11.8K
Shares

$0
0.0% of portfolio

View Full List

About IsoPlexis Corp

Ticker ISO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,405,800
Description
IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States, Canada, the United Kingdom, Belgium, France, the Czech Republic, Spain, Germany, Sweden, Italy, Israel, Switzerland, China and Taiwan, Singapore, Japan, Australia, and Korea. The company...

More about ISO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account